Kidney Transplant and Dialysis in Alström Syndrome

When kidney disease in Alström Syndrome progresses to end-stage renal disease (ESRD), patients need renal replacement therapy — either dialysis or kidney transplantation. Both options can support meaningful life for years, and the choice depends on individual factors. This article covers what's involved in each option, candidacy considerations, and what life looks like with each.

Renal replacement therapy is generally needed when:

• eGFR drops below 15 mL/min/1.73m²
• Symptoms of uremia develop (severe fatigue, nausea, mental changes)
• Fluid overload becomes hard to manage
• Severe electrolyte abnormalities can't be managed medically

In Alström, this point can be reached at variable ages — sometimes in late teens, sometimes much later in adulthood.¹

Hemodialysis

• Done at a dialysis center typically 3 times per week
• Each session 3–4 hours
• Blood is filtered through a machine
• Requires creation of a vascular access (AV fistula or graft)

Peritoneal dialysis

• Done at home
• Uses the lining of the abdomen to filter blood
• Done daily — either continuous ambulatory peritoneal dialysis (CAPD, several manual exchanges daily) or automated peritoneal dialysis (overnight on a machine)
• Requires placement of a peritoneal catheter

Considerations specific to Alström

• Vision loss can complicate home peritoneal dialysis but doesn't preclude it; assistance from family or technology supports independent management
• Cardiac function affects how well dialysis is tolerated; patients with significant cardiomyopathy may need adjusted protocols
• Diabetes management intensifies during dialysis as glucose handling changes
• Vascular access challenges may arise from previous lines, vessel anatomy²

Why transplant is generally preferred when feasible

• Better long-term survival than long-term dialysis
• Better quality of life
• More dietary flexibility
• More flexibility with travel and work
• No dialysis schedule

Candidacy

A transplant evaluation includes:

• Cardiac assessment — adequate cardiac function for surgery and immunosuppression
• Other organ assessment — liver, lungs
• Cancer screening
• Infection screening
• Psychosocial evaluation
• Multidisciplinary review

For Alström patients specifically, the multi-organ involvement is reviewed carefully. Significant cardiomyopathy or hepatic disease may affect candidacy. Some patients are candidates for combined heart-kidney transplant.³

Living vs deceased donor

• Living donor — typically family or close friend; results in better outcomes and shorter wait
• Deceased donor — wait times vary by region

Surgery

Kidney transplant is typically a 3–4 hour surgery under general anesthesia. The new kidney is placed in the lower abdomen; the original kidneys are usually left in place.

Post-transplant care

• Lifelong immunosuppression to prevent rejection
• Frequent monitoring of kidney function
• Vigilance for infections
• Cancer screening (immunosuppression increases some cancer risks)
• Coordinated care with other Alström specialists

Many adults with Alström manage dialysis successfully:

• Hemodialysis schedule limits some flexibility but provides reliable filtration
• Peritoneal dialysis offers more flexibility but requires daily commitment
• Many continue working with appropriate scheduling
• Travel becomes more complicated but possible (touring dialysis centers, planning ahead)
• Adapting to fluid and dietary restrictions
• Mental health support helps with adjustment

Successful kidney transplant typically restores:

• Better energy and physical function
• More dietary flexibility
• More travel and work flexibility
• Reduced fatigue and improved overall health

Risks include:

• Infections from immunosuppression
• Side effects of medications
• Rejection (acute or chronic)
• Other immunosuppression-related issues

Most successful kidney transplants last 10–20+ years before considering re-transplant or returning to dialysis.

Some adults with Alström develop end-stage disease in more than one organ system. In selected cases:

• Combined kidney-pancreas transplant — for patients with severe diabetes and kidney failure (the pancreas transplant addresses diabetes; less commonly performed in Alström)
• Combined heart-kidney transplant — when both organs are at end-stage
• Liver-kidney transplant — when both are involved

These multi-organ procedures are more complex and only available at experienced centers.

Decisions about transplant vs dialysis vs continuing supportive care involve:

• Medical assessment of suitability
• Patient values and priorities
• Quality-of-life considerations
• Family circumstances
• Realistic discussion of outcomes
• Palliative care can be integrated alongside disease-directed care

These discussions take time and may evolve. Your nephrology team and the broader Alström care team support the decision-making.

• Kidney Disease in Alström Syndrome
• Heart Transplant in Alström Syndrome
• End-of-Life Care and Difficult Conversations in Alström
• The Care Team for Alström Syndrome

April 30, 2026.